Make ppt Opportunistic infection in hiv
OI in HIV AIDS
Presentation · PPTX
| # | Slide Content |
|---|---|
| 1 | Title slide |
| 2 | Learning Objectives |
| 3 | What are OIs? (definition, mechanism, ART impact) |
| 4 | Section divider — CD4 & OI Risk |
| 5 | CD4 Threshold Table (>500 → <50 with specific OIs) |
| 6 | Section divider — Fungal Infections |
| 7 | Candidiasis (features + treatment, two-column) |
| 8 | PCP — Pneumocystis jirovecii (features + treatment) |
| 9 | Cryptococcal Meningitis (India ink, ampho B regimen) |
| 10 | Histoplasmosis & Coccidioidomycosis |
| 11 | Section divider — Protozoal Infections |
| 12 | Cerebral Toxoplasmosis (ring-enhancing lesions) |
| 13 | Cryptosporidium & Cystoisospora |
| 14 | Section divider — Bacterial Infections |
| 15 | TB in HIV (any CD4, HRZE regimen, IRIS) |
| 16 | Disseminated MAC (CD4 <50, clarithromycin + ethambutol) |
| 17 | Section divider — Viral Infections |
| 18 | CMV Retinitis (pizza-pie fundus, valganciclovir) |
| 19 | HSV, VZV & PML/JC Virus |
| 20 | Section divider — AIDS-Defining Malignancies |
| 21 | KS, CNS Lymphoma, Cervical Cancer |
| 22 | Section divider — Prophylaxis |
| 23 | Prophylaxis Summary Table (TMP-SMX, azithromycin, etc.) |
| 24 | IRIS — Immune Reconstitution Inflammatory Syndrome |
| 25 | Role of ART in OI prevention |
| 26 | Quick Reference Master Table (10 OIs side-by-side) |
| 27 | Key Takeaways / Conclusion |
In detail 40 to 40 slide